Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-01-25 @ 10:06 PM
Study NCT ID:
NCT06083857
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-10
First Post:
2023-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer
Sponsor:
Organization: